Cambrex on takeover hunt amid pharma fine chem consolidation

08-Feb-2012 - Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.

Danone and Mead Johnson to make united Pfizer nutrition bid?

27-Jan-2012 - Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.

Polytherics buys Warwick Effect Polymers for biodrug modification tech

23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.

Injectables maker NantWorks will give Pfizer's old Indiana facility an $85.5m makeover

12-Jan-2012 - NantWorks has unveiled plans to pump $85.5m into a new oncology and critical care injectables manufacturing plant in Terre Haute, Indiana.

Zhongxi Sunve buys stake in Chinese oncology API business

10-Jan-2012 - Zhongxi Sunve has bought a stake in a Chinese oncology API manufacturer and has further takeovers in the pipeline.

Rousselot buys Eastman Gelatine Corp in bid for pharma growth

09-Jan-2012 - Rousselot says its acquisition of Eastman Kodak’s Gel Corporation will boost its gelatine production capacity and help it meet soaring drug industry demand.

Accelrys moves into Pharma QA/QC with VelQuest acquisition

05-Jan-2012 - R&D software firm Accelrys says it will speed up the pharma QA/QC process and reduce the compliance risk ten-fold through its $35m takeover of VelQuest.

Pall to buy ForteBio to build biopharma biz

22-Dec-2011 - Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.

Vivimed expands EU, LatAm API capabilities in £35m deal

01-Dec-2011 - India-based Vivimed Labs is buying Uquifa for £35m ($55m) to add API capabilities in Europe and Latin America.

Ashland predicts ISP buy will accelerate pharma unit growth

17-Nov-2011 - Ashland expects integration of ISP and demand for pharma ingredients to drive “accelerated growth” in the next few years.

ScinoPharm goes public in preparation for expansion opportunities

05-Oct-2011 - Active pharmaceutical ingredient (API) manufacturer ScinoPharm has gone public in a bid to raise funds for its upcoming expansions.

News in brief

Berkshire Hathaway completes $9.7bn Lubrizol acquisition

20-Sep-2011 - Chemicals supplier Lubrizol was bought by Warren Buffet’s Berkshire Hathaway group last week in a deal worth $9.7bn (€7.1bn)

Another AmerisourcBergen acquisition; IntrinsiQ for $35m

07-Sep-2011 - AmerisourceBergen has bought informatics firm IntrinsiQ for $35m (€25m) continuing the spending spree it began earlier this week with the acquisition of market access consultancy Premier Source.

Chesapeake to buy Cortegra to build in US

06-Sep-2011 - Chesapeake will buy leaflet and label maker Cortegra to strengthen its manufacturing position in the US pharmaceutical packaging market.

Lactose giant DMV-Fonterra to buy Indian cellulose excipient maker Brahmar

31-Aug-2011 - DMV-Fonterra excipients (DFE) will buy Indian manufacturer Brahmar Cellulose Private Limited (BCPL) to strengthen its position in the pharmaceutical excipient market and reduce costs.

News in brief

Fareva to buy Pfizer plant to build US pharma presence

31-Aug-2011 - US drug giant Pfizer is to sell its plant in Henrico County, Virginia to Luxembourg-headquartered manufacturer Fareva.

Ashland completes ISP takeover and predicts customer benefits

25-Aug-2011 - US chemicals maker Ashland says completion of ISP takeover means simplified supply chains for drug and cosmetics industry customers.

Akela plans CMO buys after exiting development project

10-Aug-2011 - Akela Pharma is focusing on its CMO and expanding it through acquisitions after its partner exited their drug development programme.

ICIG takes Roche Colorado in bid to flex contract peptide manufacturing muscle

08-Aug-2011 - International Chemical Investors Group (ICIG) will take over Roche’s Colorado API plant in a bid to gain footing in the peptide manufacturing industry.

Pall solidifies long-term Engefiltro relationship in take-over

20-Jul-2011 - Filtration, separation and purification technology company Pall is to acquire its long-time Brazilian distribution partner, Engefiltro.

Granules and Ajinomoto OmniChem to open Indian API facility

19-Jul-2011 - Granules and Ajinomoto OmniChem have teamed up to produce high value APIs and intermediates at a new Indian plant.

Gerresheimer wants to buy into US plastic packaging sector

06-Jul-2011 - Gerresheimer is interested in a US acquisition as part of a bid to build in the North American plastic drug packaging sector.

BioMarin to buy Pfizer’s Shanbally biologics plant

27-Jun-2011 - BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.

GSK to buy China flu vaccine JV GSKNB for $39m

14-Jun-2011 - GlaxoSmithKline (GSK) has announced plans to buy its joint venture Shenzhen GSK Neptunus Biologicals (GSKNB) to expand influenza vaccine production capacity in China.